Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

South Korea to Pump US$1 Bln Into Drug Sector to Brace for FTAs (South Korea)

This article was originally published in PharmAsia News

Executive Summary

South Korea's government plans a 10-year, approximately $1.07 billion investment in its pharmaceutical industry to prepare for global trade rules under a U.S.-South Korea Free Trade Agreement (FTA). Analysts believe South Korea's domestic drug industry will lose around 168.8 billion won annually to tough U.S. competition if FTA rules are implemented. (Click here for more
Advertisement

Related Content

South Korea-U.S. Free Trade Agreement Likely To Put Stranglehold On Local Korean Drug Makers
Advertisement
UsernamePublicRestriction

Register

SC066361

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel